Shares of CVS Health Co. (NYSE:CVS – Get Free Report) traded up 1.5% on Tuesday after Evercore ISI raised their price target on the stock from $60.00 to $65.00. Evercore ISI currently has an outperform rating on the stock. CVS Health traded as high as $57.33 and last traded at $57.03. 2,609,261 shares traded hands during trading, a decline of 80% from the average session volume of 13,086,002 shares. The stock had previously closed at $56.20.
Several other brokerages also recently weighed in on CVS. Deutsche Bank Aktiengesellschaft upgraded CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective for the company in a research report on Tuesday, December 3rd. TD Cowen increased their target price on CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, November 25th. Wells Fargo & Company upgraded CVS Health from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $60.00 to $66.00 in a research report on Monday, November 18th. UBS Group increased their target price on CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a research report on Thursday, November 7th. Finally, Barclays dropped their target price on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $68.12.
View Our Latest Analysis on CVS Health
Institutional Investors Weigh In On CVS Health
CVS Health Stock Down 0.6 %
The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The stock has a fifty day moving average price of $51.27 and a two-hundred day moving average price of $56.18. The company has a market cap of $71.73 billion, a P/E ratio of 14.47, a price-to-earnings-growth ratio of 0.80 and a beta of 0.59.
CVS Health (NYSE:CVS – Get Free Report) last posted its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. During the same quarter last year, the company earned $2.21 earnings per share. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. On average, research analysts expect that CVS Health Co. will post 5.22 EPS for the current year.
CVS Health Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be issued a dividend of $0.665 per share. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 4.67%. CVS Health’s dividend payout ratio (DPR) is currently 67.51%.
CVS Health Company Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Stories
- Five stocks we like better than CVS Health
- How Can Investors Benefit From After-Hours Trading
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Consumer Staples Stocks, Explained
- 3 Steel Stocks Soaring After Tariff Announcements
- 10 Best Airline Stocks to Buy
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.